Stockreport

Immune Pharmaceuticals and Vector Therapeutics sign option agreement for worldwide Ceplene rights [Seeking Alpha]

IMMUNE PHARMACEUTICALS INC NE  (IMNP) 
US:NASDAQ Investor Relations: immunepharma.com/investor-relations
PDF Immune Pharmaceuticals and Vector Therapeutics sign option agreement for worldwide Ceplene rights [Read more]